Trial intelligence / Profile preview

Bedrocan for Fibromyalgia Pain

NCT05939466Phase 4Completed

Sponsor
University of Basilicata
Start
Mar 2021
Primary completion
Sep 2021
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of Bedrocan in fibromyalgia (FM), sponsored by University of Basilicata. Started Mar 2021; status: completed.

02

Drugs

Bedrocan
03

Conditions

fibromyalgia (FM)

Beyond the preview

Go deeper on NCT05939466.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT05939466.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call